Katja Deterding

Carl Neuberg Str. 1
Hannover, NI 30625, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 88 publications

Acute HEV Infection Is a Relevant Cause of Decompensation and ACLF in Patients With Liver Cirrhosis.

Acute HEV Infection Is a Relevant Cause of Decompensation and ACLF in Patients With Liver Cirrhosis.

Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: September 22, 2025

Quality of life improves during antiviral therapy with bulevirtide.

Quality of life improves during antiviral therapy with bulevirtide.

Journal: Zeitschrift fur Gastroenterologie
Published: September 11, 2025

Impact of Handling Perception and Language Barriers on Virologic Response to Daily Subcutaneous Bulevirtide in Hepatitis D.

Impact of Handling Perception and Language Barriers on Virologic Response to Daily Subcutaneous Bulevirtide in Hepatitis D.

Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: August 09, 2025

Transient Interferon-Driven Natural Killer Cell Activation in Acute Hepatitis C.

Transient Interferon-Driven Natural Killer Cell Activation in Acute Hepatitis C.

Journal: The Journal of infectious diseases
Published: August 06, 2025

Treatment response to bulevirtide is linked to amelioration of portal hypertension in patients with chronic hepatitis D.

Treatment response to bulevirtide is linked to amelioration of portal hypertension in patients with chronic hepatitis D.

Journal: JHEP reports : innovation in hepatology
Published: May 20, 2025

Metabolic Dysfunction-Associated Steatohepatitis Diagnosis and Management in Germany: Insights From an Expert Consensus Panel.

Metabolic Dysfunction-Associated Steatohepatitis Diagnosis and Management in Germany: Insights From an Expert Consensus Panel.

Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: April 30, 2025

Distinct inflammatory imprint in non-cirrhotic and cirrhotic patients before and after direct-acting antiviral therapy.

Distinct inflammatory imprint in non-cirrhotic and cirrhotic patients before and after direct-acting antiviral therapy.

Journal: Clinical and molecular hepatology
Published: March 20, 2025

Secondary hyperparathyroidism in adult congenital heart disease: the CHD-HYPER-study.

Secondary hyperparathyroidism in adult congenital heart disease: the CHD-HYPER-study.

Journal: European heart journal open
Published: December 13, 2024

HBV Dominance Is Associated With a Distinct Inflammatory Milieu in HBV/HCV Coinfection.

HBV Dominance Is Associated With a Distinct Inflammatory Milieu in HBV/HCV Coinfection.

Journal: Journal of viral hepatitis
Published: November 22, 2024

Value and Kinetics of Virological Markers in the Natural Course of Chronic Hepatitis D Virus Infection.

Value and Kinetics of Virological Markers in the Natural Course of Chronic Hepatitis D Virus Infection.

Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: September 30, 2024

Enhancing HBV-specific T cell responses through a combination of epigenetic modulation and immune checkpoint inhibition.

Enhancing HBV-specific T cell responses through a combination of epigenetic modulation and immune checkpoint inhibition.

Journal: Hepatology (Baltimore, Md.)
Published: September 20, 2024

TIGIT expression on natural killer cell subsets is an early indicator of alleviating liver inflammation following bulevirtide treatment in chronic hepatitis D.

TIGIT expression on natural killer cell subsets is an early indicator of alleviating liver inflammation following bulevirtide treatment in chronic hepatitis D.

Journal: Hepatology (Baltimore, Md.)
Published: August 21, 2024
Showing 1-12 of 88

Last Updated: 09/26/2026